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ABSTRACT 
BOLD RESPONSES TO INHIBITION IN CANNABIS USING ADOLESCENTS AND 
EMERGING ADULTS 
by 
Alexander L. Wallace  
The University of Wisconsin-Milwaukee, 2019 
Under the Supervision of Professor Krista M. Lisdahl 
Cannabis use has been associated with increased blood oxygen level dependent (BOLD) 
responses absent of behavioral deficits during a response inhibition task compared to controls. 
We investigated whether gender and cannabis use result in differences in BOLD responses and 
behavioral performance during a Go-NoGo task. Participants included eighty-three 16-26 year 
olds (MJ=36, Controls=46). An emotion based Go-NoGo task required participants to inhibit 
their response during a “neutral” face. A whole-brain analysis looked at differences between 
cannabis group, gender, and their interaction. Significant increased BOLD responses were 
observed in cannabis users compared to controls in the left frontal cortex, left cingulate cortex, 
and the left thalamus during correct response inhibitions. There were no significant differences 
on task performance or group by gender interactions. Supporting previous research, cannabis 
users showed increased BOLD responses in core areas associated with response inhibition during 
a Go-NoGo task further elucidating the relationships between cannabis and brain-behavior.  
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Cannabis use remains one of the most commonly used drugs by adolescents and 
emerging adults with 37.1% of high school seniors and approximately 35.3% of young adults 
(aged 19-28) reported using cannabis in the past 12 months (Johnston et al., 2018; Schulenberg 
et al., 2017). Due to the ongoing brain development during this time (Giedd et al., 1999), 
research suggests that adolescent cannabis use has significant negative impact on brain structure 
and function (Crane, Schuster, Fusar-Poli, & Gonzalez, 2013; Lubman, Cheetham, & Yücel, 
2015; A. D. Schweinsburg, Brown, & Tapert, 2008).  
Cannabis contains the compound Δ9-tetrahydrocannabional (THC), which is responsible 
for its psychoactive effects (Hall & Solowij, 1998). THC bonds with cannabinoid receptors that 
are located within both the central and peripheral nervous system (Mackie, 2005). The 
cannabinoid receptor 1 (CB1) is the most abundant cannabinoid receptor found in the brain 
(Chevaleyre, Takahashi, & Castillo, 2006) and stimulation of CB1 is responsible for the 
psychoactive effects of THC (Mackie, 2005; Wilson & Nicoll, 2002). High density of CB1 
receptors have been found in the amygdala (Katona et al., 2001), basal ganglia (Herkenham et 
al., 1991), hippocampus (Herkenham et al., 1991; Jansen, Haycock, Ward, & Seybold, 1992), 
and prefrontal and parietal cortices (Auclair, Otani, Soubrie, & Crepel, 2000). In these regions, 
THC binds with CB1 receptors primarily on presynaptic gamma-aminobutyric acid (GABA) 
neurons to inhibit and excite neurotransmitter activity such as glutamate, dopamine, 
acetylcholine, and serotonin (Katona et al., 1999; Lopez-Moreno, Gonzalez-Cuevas, Moreno, & 
Navarro, 2008). Disruption of the natural endocannabinoid system during development by 
repeated exogenous cannabis may result in neurocognitive deficits, especially in CB1-rich areas 
underlying executive functioning (Casey, Getz, & Galvan, 2008; Casey & Jones, 2010; Lisdahl, 
Gilbart, Wright, & Shollenbarger, 2013; Lopez-Moreno et al., 2008). 
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Executive functioning is a core cognitive function responsible for engaging in purposeful, 
independent, self-directed behaviors (Lezak, 2012). Facets of executive functioning include 
planning and decision-making, selective attention, volition, task-switching, and behavioral 
inhibition (Hofmann, Schmeichel, & Baddeley, 2012; Lezak, 2012). Prior work has reported that 
chronic cannabis use has been linked with executive functioning deficits (Gonzalez et al., 2012; 
Grant, Chamberlain, Schreiber, & Odlaug, 2012; Hanson et al., 2010; Harvey, Sellman, Porter, & 
Frampton, 2007; Lisdahl & Price, 2012; Mathias et al., 2011; Medina et al., 2007; Schuster, 
Crane, Mermelstein, & Gonzalez, 2012). Specifically, studies have shown that cannabis use is 
associated with decreased complex attention (Hanson et al., 2010; Lisdahl & Price, 2012; 
Mathias et al., 2011; Medina et al., 2007; Tapert, Baratta, Abrantes, & Brown, 2002), verbal 
working memory deficits, (Becker, Collins, & Luciana, 2014; Dougherty et al., 2013; Hanson et 
al., 2010; Medina et al., 2007; Solowij et al., 2011), poorer decision making (Becker et al., 2014; 
Churchwell, Lopez-Larson, & Yurgelun-Todd, 2010; Gonzalez et al., 2012; Grant et al., 2012), 
and planning (Grant et al., 2012; Medina et al., 2007). With continued links between substance 
use and response inhibition (Fillmore & Rush, 2002; Monterosso, Aron, Cordova, Xu, & 
London, 2005; Nigg et al., 2006) and increased calls to examine inhibitory control as a future 
predictor of use (Ivanov, Schulz, London, & Newcorn, 2008) the role of cannabis on areas of the 
brain related to inhibition has garnered particular interest.  
Inhibition is a key component to executive control and attention that is best defined as the 
ability to suppress responses to a stimulus (Aron, 2007). The concept of inhibition is complex 
and can be broken down into 4 subsets or processes, interference control, cognitive inhibition, 
behavioral inhibition, and oculomotor control (Nigg, 2000). While these differing inhibitory 
processes have distinct implications, the subtype that has garnered significant interest is the role 
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of behavioral inhibition, also thought of as response inhibition (Aron, 2007; Chambers, Garavan, 
& Bellgrove, 2009; Ridderinkhof, van den Wildenberg, Segalowitz, & Carter, 2004). Behavioral 
inhibition is one’s ability to suppress automatic/prepared/cued responses to a task, which is often 
measured through tasks such Go-NoGo or Stop tasks (Nigg, 2000). With continuing advances in 
imaging data, the relationship between response inhibition performance on these tasks and the 
brain has garnered increasingly more research interest. 
While it has long been known that the process of inhibition has been linked to the 
prefrontal cortex (Holmes, 1938), extensive research has been done to uncover the specific 
regions associated with response inhibition. In particular, regions of the prefrontal cortex 
including the inferior frontal gyrus (IFG) [both right (Aron, Fletcher, Bullmore, Sahakian, & 
Robbins, 2003; Aron, Robbins, & Poldrack, 2004, 2014; Hampshire, Chamberlain, Monti, 
Duncan, & Owen, 2010) and left (Swick, Ashley, & Turken, 2008)], dorsomedial prefrontal 
cortex (Garavan, Ross, Murphy, Roche, & Stein, 2002), and the anterior cingulate cortex (Carter 
& van Veen, 2007). Regions outside of the prefrontal cortex have also been implicated in 
response inhibition, in particular the basal ganglia (Chambers et al., 2009; Rieger, Gauggel, & 
Burmeister, 2003), which is associated with motor suppression. Due to the varying regions that 
play a role in inhibition, problems within this cognitive domain may be linked to damage or 
dysfunction within several of the aforementioned regions. Further, as adolescents emerge into 
young adulthood, these regions in particular experience neuromatruation (Casey et al., 2008; T. 
L. Jernigan, Trauner, Hesselink, & Tallal, 1991). The regular exposure of exogenous cannabis 
during this developmental period may significantly disrupt the functioning of these neuronal 
networks (Casey & Jones, 2010; Ehrenreich et al., 1999; A. D. Schweinsburg et al., 2008).  
 
4 
As mentioned above, cannabis use has been associated with inhibitory deficits on tasks 
such as the Stroop (Battisti et al., 2010; Fontes et al., 2011; Gruber & Yurgelun-Todd, 2005),  
Go-NoGo related tasks (Bolla, Brown, Eldreth, Tate, & Cadet, 2002), and decision making tasks 
(Solowij et al., 2012). These inhibitory deficits have been shown to moderate the relationship 
between cannabis use and negative behavioral outcomes, such as risky sexual behavior (Schuster 
et al., 2012). While these deficits have been shown within attention based tasks (Battisti et al., 
2010; Bolla et al., 2002; Fontes et al., 2011; Gruber & Yurgelun-Todd, 2005; Solowij et al., 
2012) and self-report measures (Gruber, Silveri, Dahlgren, & Yurgelun-Todd, 2011), some 
studies suggest that no observable differences with response inhibition in young adult cannabis 
users (Gonzalez et al., 2012; Grant et al., 2012). It is possible that there are still subtle 
differences in the inhibitory network, even in the absence of downstream behavioral deficits. 
Further, cannabis users have shown increased activity in attention based networks (Abdullaev, 
Posner, Nunnally, & Dishion, 2010) and cerebral blood flow in brain regions pertinent to 
inhibition (Vaidya et al., 2012) during tasks requiring executive function. These findings suggest 
that cannabis users require increased effort or compensatory resources in order to inhibit 
responses.  
Only a handful of imagining studies have directly examined BOLD responses cannabis 
users engaging in an inhibitory functional magnetic resonance imaging (fMRI) task (Behan et al., 
2014; Gruber & Yurgelun-Todd, 2005; A. M. Smith et al., 2011; Tapert et al., 2007). These 
studies have largely found that while there are no significant behavioral differences in task 
performance, adolescent and young adult cannabis users display significantly more BOLD 
activation in brain regions related to response inhibition compared to controls (J. L. Smith, 
Mattick, Jamadar, & Iredale, 2014; Tapert et al., 2007). Across multiple studies, cannabis users 
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were shown to have greater BOLD responses within brain regions of interest (ROI’s) that are 
linked with inhibitory processes as well as recruited additional neighboring brain regions to 
complete the inhibitory task. Specifically, cannabis users demonstrated aberrant activation in the 
anterior cingulate cortex (Gruber, Dahlgren, Sagar, Gonenc, & Killgore, 2012; Hester, Nestor, & 
Garavan, 2009), right insula (Hester et al., 2009; A. M. Smith et al., 2011; Tapert et al., 2007), 
dorsolateral prefrontal cortex (Gruber & Yurgelun-Todd, 2005; A. M. Smith et al., 2011; Tapert 
et al., 2007), superior frontal gyri (Behan et al., 2014; J. L. Smith et al., 2014; Tapert et al., 
2007), inferior frontal gyri (Behan et al., 2014; J. L. Smith et al., 2014), and inferior parietal 
lobules (Behan et al., 2014; A. M. Smith et al., 2011; Tapert et al., 2007) during inhibitory tasks. 
However, these studies notably had relatively small samples (N=18-35) and were predominately 
male; thus, additional research is needed to understand neuronal response to inhibitory control 
tasks in cannabis users. 
Of further interest is whether gender moderates these effects. As mentioned above, most 
neuroimaging studies looking at cannabis use with response inhibition are predominately male. 
In animal models, THC exposure has been shown to down-regulate CB1 receptors more in 
female brains compared to their male counterparts (Burston, Wiley, Craig, Selley, & Sim‐Selley, 
2010). Through ovarian hormones, female rats have also been shown to have significantly 
decreased density of CB1 receptors in the prefrontal cortex and amygdala compared to males as 
well as a more hyperactive profile and lower prepulse inhibition (Paola Castelli et al., 2014). 
These findings suggest that female populations may be more susceptible to neurocognitive 
deficits from cannabis that were highlighted above.  However, while these findings within 
animal models are important, gender effects of cannabis and cognition in human populations 
have been limited (Craft, Marusich, & Wiley, 2013; Fattore & Fratta, 2010).  
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Most human studies to date have not reported gender differences in the effects of 
cannabis on verbal learning (Crane, Schuster, & Gonzalez, 2013; Solowij et al., 2011), memory 
(Pope, Jacobs, Mialet, Yurgelun-Todd, & Gruber, 1997; Solowij et al., 2011), and inhibitory 
control (Crane, Schuster, & Gonzalez, 2013). However, two studies have found that male 
cannabis users demonstrated impaired psychomotor speed (Lisdahl & Price, 2012) and poorer 
decision making (Crane, Schuster, Fusar-Poli, et al., 2013) compared to male controls while 
females did not show this effect. In contrast, studies have found that heavier using females 
cannabis users demonstrated poorer visuospatial (Pope et al., 1997) and verbal memory 
compared to male cannabis users (Crane, Schuster, & Gonzalez, 2013). Further, female 
adolescent cannabis users have shown marginally increased prefrontal cortex volumes and larger 
right amygdala volumes compared to female controls (McQueeny et al., 2011; Medina et al., 
2009). While these findings have not been replicated within functional studies, these altered 
brain volumes suggest that female cannabis users may be at greater risk from cannabis exposure 
compared to male users. However, these gender findings are still in the preliminary stages and 
animal models examining gender and cannabis remain relatively mixed (Crane, Schuster, Fusar-
Poli, et al., 2013),. Most notably, gender differences in the impact of cannabis use on inhibition 
are particular scarce. While studies have largely not found any gender differences in response 
inhibition between cannabis users and their non-using counterparts, these studies also did not 
observe deficits with inhibition in cannabis users at all and did not examine fMRI BOLD 
response (Crane, Schuster, & Gonzalez, 2013; Lisdahl & Price, 2012).  
The purpose of the current study is to investigate the relationship between cannabis use 
and brain functioning during an inhibitory task and how these effects may differ between males 
and females.  We hypothesize that despite having similar behavioral performance on an fMRI 
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task, cannabis users will demonstrate significantly increased BOLD responses compared to 
controls during correct inhibitions on the Go-NoGo task in the right dorsolateral prefrontal 
cortex, bilateral medial frontal, bilateral inferior and superior parietal lobules, middle, inferior, 
superior frontal gyri, and in neighboring brain regions as well as aberrant BOLD responses in the 
anterior cingulate cortex. Finally, we hypothesize that there will be altered functional activity 
between male and female users, with female users experiencing increased compensatory BOLD 
activation and increased help from neighboring brain regions of key inhibitory ROIs during 
successful inhibitions on the Go-NoGo task compared to male users and controls. 
Method 
Participants 
The proposed study utilized data from 82 participants collected from a larger parent study 
investigating frontolimbic functioning in cannabis using youth (R01 DA030354; PI: Lisdahl). 
Participants were recruited through flyers and advertisements in the local community and college 
campuses. Participants were included if they were 16-26 years-old, right handed, spoke English, 
were willing to abstain from substance use over a 3-week period, and fit into either a cannabis 
user or non-user (see below). Exclusion criteria included having an independent DSM-IV Axis I 
(attention, mood, anxiety or psychotic) disorder in the past year, major medical or neurological 
disorders, traumatic brain injury or head trauma (loss of consciousness >2 minutes), history of 
learning disability or intellectual disability, prenatal medical issues or premature birth (gestation 
<35 weeks), reported prenatal alcohol/illicit drug exposure, inability to complete exercise 
physiology testing, or excessive other drug use (>20 times of lifetime use for each drug 
category). Cannabis Users (n=36): In order to capture current cannabis users, cannabis users had 
to have endorsed using cannabis greater than 40 times in the past year (nearly weekly). Controls 
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(n=46) were defined as having abstained from using cannabis more than 5 times in the past year. 
A total of 44 males and 38 females were included in the study. After grouping participants into 
cannabis users and controls, cannabis users included 21 males and 25 females (Males=46%) and 
controls include 23 males and 13 females (Males=64%).  
Procedures 
 All procedures were IRB-approved through the University of Wisconsin – Milwaukee 
and the Medical College of Wisconsin. Potential participants who expressed interest in the parent 
study were screened through an initial semi-structured interview for independent past-year Axis I 
disorders other than substance use disorder (SUD) over the phone. If determined eligible, study 
staff obtained written consent from participants (aged 18 or older). All minors below 18 years of 
age provided written assent after parent consent was acquired. Participants who were deemed 
ineligible were informed and compensated, but not told the specific reasons for failed inclusion. 
Participants who were eligible for the study came in for five study sessions over the 
course of three weeks. Data from the baseline session (day 1) and fourth session (day 20 of 21) 
are assessed here. Participants completed a series of psychological questionnaires, drug use 
interview, neuropsychological battery, and an MRI scan over the course of three weeks. During 
that period, participants were required to remain abstinent from alcohol, cannabis, and other drug 
use, which was confirmed through urine and sweat toxicology screening. 
Measures 
MINI Psychiatric Interview. To rule out for potential Axis-I Disorders to prevent 
comorbid psychiatric history from confounding results, participants and parents of participants 
over 18 were given the Mini International Psychiatric Interview (MINI) (Sheehan et al., 1998), 
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and participants and parents of participants under 18 were given the MINI-Kid (Sheehan et al., 
2010). 
Customary Drinking and Drug Use Record. To determine lifetime patterns of drug and 
alcohol use, youth participants were given the Customary Drinking and Drug Use Record 
(CDDR) (Brown et al., 1998) at baseline. The CDDR measured the frequency of alcohol, 
nicotine, cannabis, and other drug use, substance use disorder symptoms, and the age of onset for 
first time substance use as well as regular weekly use. 
Timeline Followback. Timeline Follow-Back interviews were conducted with all 
participants to measure substance use patterns over the past year (Sobell & Sobell, 1992). 
Utilizing memory cues of common holidays and personal events, participants were asked to 
describe the frequency of their drug use over the past year by a month-to-month basis. Memory 
cues were adapted to be appropriate to both adolescents and emerging adults and included things 
such as developmental milestones, school grades, and relationship changes. Substances were 
measured by standard units [alcohol (standard drinks), nicotine (number of cigarettes and hits of 
chew/snuff/pipe/cigar/hookah), cannabis (all methods converted to joints or mg in concentrates), 
ecstasy (number of tablets), sedatives (number of pills or hits of downers and GHB), stimulants 
(cocaine and methamphetamine use converted to mg and number of amphetamine pills), 
hallucinogens (number of hits or uses of ketamine/salvia/shrooms/other hallucinogens), opioids 
(number of hits of heroin/opium), and inhalants (number of hits)]. 
 Drug Toxicology/Abstinence Testing. To insure abstinence during the course of the study, 
participants were required to complete immediate urine drug toxicology screenings. Screenings 
were conducted using ACCUTEST SplitCup to test for the presence of the following substances: 
amphetamines (1000 ng/ml), barbiturates (300 ng/ml), benzodiazepines (300 ng/ml), cocaine 
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(300 ng/ml), ecstasy (MDMA; 500 ng/ml), methadone (300 ng/ml), methamphetamine (1000 
ng/ml), opiates (2000 ng/ml), PCP (25 ng/ml), and THC (marijuana; 50 ng/ml). Further, NicAlert 
was also used to measure cotinine levels within participants’ urine samples. Participants were 
also required to wear PharmChek Drugs of Abuse Patches throughout the duration of the study. 
Sweat drug patches were made of a semi-permeable polyurethane membrane that allowed for the 
natural secretion of water/sweat, but collects heavier molecules such as illicit drugs. In this way, 
drug use that quickly leaves the system, such as amphetamines, would be detected during the 
week period between testing sessions. Sweat patches were tested for amphetamine, 
methamphetamine, opiates, cocaine metabolites, PCP, and THC. 
CPT. The Conners Continuous Performance Task (CPT) is a 14 minute long task that 
required individuals to respond to stimuli on a computer screen (Conners et al., 2000). 
Participants were asked to respond to all letters except for the letter “X” which they should try to 
stop themselves from pressing the response button. During this task, average reaction time across 
all “go” trials were recorded. Previous research has shown that cannabis users have significantly 
differed from controls on reaction time during this task (Wallace, Wade, Hatcher, & Lisdahl, 
2018). 
 fMRI Affective No-Go Task. Participants were exposed to a Go-NoGo task featuring faces 
expressing feelings of happy, fearful, or calm that had been originally designed by the research 
group at Sackler Institute for Developmental Psychobiology (Hare et al., 2008; Somerville, Hare, 
& Casey, 2011). For this NoGo task, two facial expressions were used within a trial.  Using a 
rapid event-related design, participants were told what particular stimuli/expression they should 
respond to by hitting a target box (Go), and what stimuli/expression they should stop themselves 
from responding and hitting the target box (NoGo). For each trail, faces would appear for 500 
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milliseconds followed by a jittered intertrial interval ranging from 2 to 14.5 seconds in duration. 
In each run, the participants were exposed to 48 trials that were presented is a pseudorandomized 
order (35 “go” trials and 13 “nogo” trials).  Participants completed six trials, which allowed 
every combination of happy, fearful, and calm expressions to appear as a Go and NoGo trial for 
each participant.  Further, for each trial, participants were instructed to respond as fast as 
possible and not wait for the target/nontarget stimuli, but also try to make as few errors as 
possible. 
MRI Data Acquisition  
MRI scans were acquired on a 3T Signa LX MRI scanner (GE Healthcare, Waukesha, 
WI) using a 32-channel quadrature transmit/receive head coil. High-resolution anatomical 
images were acquired using a T1-weighted spoiled gradient-recalled at steady-state (SPGR) 
pulse sequence (TR = 8.2 ms, TE = 3.4 s, TI = 450 and flip angle of 12°). The in-plane resolution 
of the anatomical images was 256x256 with a square field of view (FOV) of 240 mm. One 
hundred fifty slices were acquired at 1 mm thickness. 
MRI Pre-Processing Plan 
Data were processed and analyzed using Analysis of Functional NeuroImages (AFNI 
(Cox, 1996)) and Matlab (Matheworks, 2012). Imaging data were processed through a standard 
preprocessing pipeline within AFNI. To account for high and low frequency artifactual signals 
caused by hardware instabilities, head motion, and physiological changes, the time series per 
each voxel were “despiked” and these isolated spikes were replaced to fit the modeled data for 
the voxel utilizing 3dDespike. Further, the first 3 TRs (time it took to conduct one full scan) 
were removed to eliminate initial scanner “noise.” Voxel time series were corrected so that all 
acquired data is aligned to the same temporal spot of origin utilizing AFNI’s 3dTshift. To further 
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reduce the influence of head motion within the BOLD signal, volume registration were registered 
based on the volume run with the least amount of motion artefacts within the dataset and then 
warped into standard Montreal Neurological Institute (MNI) coordinate space (Mazziotta et al., 
2001) by making use of AFNI’s 3dVolreg. Using 3dmerge, data were spatial smoothed using a 
Gaussian function using the default 4mm full width at half maximum (FWHM) to blur data to 
half of other surrounding voxels. Each voxel was scaled by default to a mean of 100 to allow for 
interpretation of echo-planar imaging (EPI) values as a percentage of the mean. Data was 
deconvolved using AFNI’s 3dDeconvolve (Ward, 2000). Data was convolved after a gamma 
variate function. Further, six motion parameters were regressed out (roll, pitch, yaw, ds, dl, and 
dp) to account for motion artifacts. Data points of incorrect responses on the Go-NoGo trial were 
removed from data in order to compare correct neutral Go-NoGo stimuli across cannabis users 
and controls. In this way, we only examined correct inhibitory responses to the neutral NoGo 
stimuli. Bold signal responses during these correctly inhibited neutral NoGo were used to 
compare across cannabis users and controls. 
Statistical Analyses 
Preliminary Analysis. Analyses were conducted utilizing AFNI with follow-up analyses 
occurring in SPSS. All statistical decisions were made at a p value less than .05. Demographic 
information was examined using chi-square and ANOVA testing. Successful NoGo performance 
between both groups were observed to determine if cannabis users and controls have similar 
rates of accuracy during the task. Group comparisons on these commission errors were evaluated 
using an ANCOVA with past year alcohol use as a covariate.  
Primary Analysis. BOLD responses were compared across subject’s time series at points 
when subject’s correctly inhibited their response during a neutral NoGo stimuli. In order to 
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optimize the number of neutral NoGo data points per a subject, trials that included both happy 
Go and fearful Go were concatenated together. However, as a follow-up analysis, correct neutral 
NoGo responses were compared between both the happy Go and fearful Go trials. To examine 
group differences, a voxel by voxel ANCOVA was conducted using AFNI’s 3dMVM at a voxel-
wise p-value of p=.01. Monte carlo simulation for cluster-thresholding was completed using 
3dFWHM and 3dClustSim (Forman et al., 1995) to control for multiple comparisons at a p-value 
of .05. In order to investigate whether gender moderates the effect between cannabis use and 
BOLD responses, AFNI’s 3dMVM incorporated models including gender and cannabis use. In 
this way, F-statistical maps were computed to determine significant interactions between gender 
and cannabis use after controlling for past year alcohol use as a covariates. Similar to the primary 
analyses, cluster-thresholding was conducted using 3dClustSim (Forman et al., 1995).  
Follow-Up Analyses. In order to examine brain-behavior relationships, significantly 
different ROI clusters between cannabis users and non-users were extracted into SPSS (beta 
weights) and correlated with CPT-II scores.  
Results 
Demographics 
 Controls and cannabis users did not significantly differ in age (t(80)=-.842, p=0.40), 
years of education (t(80)=.98, p=0.31), race (χ2=3.83, p=0.70), ethnicity (χ2=3.62, p=0.16), or 
gender (χ2=2.70, p=0.10). Demographic information is displayed in Table 1. 
Table 1. 
Demographics 
 Age  
(M,SD) 
Race 
(% Caucasian) 
Ethnicity 
(% Not Hispanic) 
Gender 
(% Male) 
Years of 
Education 
(M,SD) 
MJ Users 21.6 (2.2) 58.3% 77.8% 63.9% 14.0 (1.5) 
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Controls 21.1 (2.5) 65.2% 89.1% 45.7% 14.4 (2.1) 
Notes. *MJ denotes the cannabis user group 
Substance Use 
 Controls had on average .54 cannabis uses in the past year (SD=1.17, Min=0.00, 
Max=4.75), used alcohol on average 132.97 times in the past year (SD=189.23, Min=0.00, 
Max=698.50), and used an average of 25.82 cigarettes in the past year (SD=171.71, Min=0.00, 
Max=1165.00). Cannabis users had 425.51 cannabis uses on average in the past year 
(SD=441.75, Min=44.70, Max=2306.00), alcohol 331.52 on average in the past year 
(SD=299.52, Min=0.00, Max=1120.50), and 184.59 cigarettes in the past year (SD=460.91, 
Min=0.00, Max=1867.00). Cannabis users last reported cannabis use on average was 31.08 days 
(SD=22.90, Min=17.00, Max=150) before the MRI scan (including the 3 weeks of monitored 
abstinence). As expected, cannabis users and controls differed significantly on past year cannabis 
use (t(35)=5.78, p<.001) and past year alcohol use (t(56)=3.47, p=.001). Past year nicotine use 
was not significantly different between cannabis users and controls (t(43)=1.96, p=.06). Due to 
the significant differences in alcohol use, past year alcohol use will be incorporated into the 
statistical analyses. 
Behavioral Measures 
 Cannabis users did not significantly differ on the number of incorrect responses to fMRI 
Neutral NoGo stimuli (M=1.58, SD=1.75) compared to controls (M=2.44, SD=2.41, t(80)=-1.78, 
p=.08). These findings were also non-significant after controlling for alcohol (cannabis users: 
estimated mean=1.78, SE=0.37; controls: estimated mean=2.28, SE=0.32) (F(1)=.824, p=0.37). 
There were no significant differences between males and females on incorrect NoGo responses 
(t(80)=0.133, p=0.89). Cannabis users did not significantly differ on Go stimulus reaction time 
(M=541.12, SD=90.82) compared to controls (M=518.20, SD=79.07, t(80)=1.22, p=.23) nor did 
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cannabis users differ on omission errors (M=1.08, SD=1.59) compared to controls (M=2.02, 
SD=3.96, t(80)=-1.34, p=.18). 
fMRI Responses 
 Cannabis Effects. Whole brain analyses showed that during correct inhibitory responses 
to neutral NoGo trials, cannabis users showed significant clusters of increased BOLD responses 
in the left Cingulate Gyrus, the left Superior Frontal Gyrus, the left Thalamus, the left Medial 
Frontal Gyrus, and right Cerebellum compared to their control counterparts (see Table 2, Figure 
1). Cannabis users did not display any significant clusters of decreased BOLD activation 
compared to controls.  
Table 2. 
Regions of Increased BOLD Responses in Cannabis Users 
Cluster # Voxels MNI coordinatesa Annotations Effect Size 
Cohen’s d Peak x Peak y Peak z 
1 167 +4.5 -19.5 +37.5 Left Cingulate Gyrus 0.69908 
2 102 +22.5 -49.5 +22.5 Left Superior Frontal Gyrus 0.71082 
3 101 +4.5 +13.5 +7.5 Left Thalamus 0.68041 
4 74 +7.5 -58.5 -1.5 Left Medial Frontal Gyrus 0.70428 
5 73 -31.5 +67.5 -25.5 Right Declive (Cerebellum VI) 0.70518 
Notes. aMNI coordinates refer to peak signal intensity group difference within the cluster 
Figure 1. 
BOLD Responses in Cannabis Users vs. Controls 
 
Figure 1. Displays regions of increased significant BOLD responses in cannabis users compared to controls during correct 
inhibitions during “neutral” NoGo trials. Increased BOLD responses in the left Superior Frontal Gyrus, left Cingulate Gyrus, 
left Thalamus, left Medial Frontal Gyrus, and right cerebellum are displayed in the sagittal view with numbers above each 
slice indicating the position of the slice in X coordinates in MNI space.  
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Cannabis*Gender Effects. Gender. Female participants showed significant clusters of 
increased BOLD response in the bilateral Posterior Cingulate, left Medial Frontal Gyrus, right 
Cerebellum, left Superior Occipital Gyrus, the right Cingulate Gyrus, and the left Thalamus 
during correct NoGo activation. Cannabis*Gender. There were no significant clusters that 
survived correction for the interaction between cannabis use and gender. Covariates. Past year 
alcohol use did predict increased BOLD activation within the left Inferior Parietal Lobule.  
 Happy vs Fearful Go Trials. Follow up whole brain analyses of correct neutral NoGo 
and happy Go trials showed significant clusters in the left Anterior Cingulate Cortex, the left 
Middle Frontal Gyrus, and the left Parahippocampal Gyrus (see Figure 2). There were no 
significant clusters that survived correction in the trial with fearful go stimulus. 
 
Brain-Behavior Relationships 
 Beta values from regions displaying increased BOLD responses in cannabis users were 
not significantly correlated with the Connor CPT, but did show slight positive correlations (see 
Table 3) with increased reaction time and increased beta values in the left cingulate gyrus 
Figure 2. 
BOLD Responses in Cannabis Users vs Controls in Happy Go Trials 
 
Figure 2. Displays regions of increased significant BOLD responses in cannabis users compared to controls during correct 
inhibitions during “neutral” NoGo trials on trials where the Go stimulus was a “happy” face. Increased BOLD response in the 
left Frontal Middle Gyrus, left Parahippocampal Gyrus, and the left Cingulate Gyrus are displayed in the sagittal view with 
numbers above each slice indicating the position of the slice in X coordinates in MNI space. 
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(r(80)=0.10, p=0.37), left superior frontal gyrus (r(80)=0.11, p=0.33), and the left medial frontal 
gyrus (r(80)=0.18, p=0.10).  
Table 3. 
Pearson Correlations of Beta Coefficients of Significant ROI’s 
 
Left  Cingulate  
Gyrus   
Coefficients 
Left Superior 
Frontal Gyrus 
Coefficients 
Left 
Thalamus 
Coefficients 
Left Medial 
Frontal 
Gyrus 
Coefficients 
Right 
Cerebellum 
Coefficients 
CPT 
Average 
Hit 
Response 
Time 
Left Cingulate 
Gyrus 
Coefficients 
1 .661** .639** .521** .649** 0.100 
Left Superior 
Frontal Gyrus 
Coefficients 
.661** 1 .536** .412** .548** 0.109 
Left Thalamus 
Coefficients 
 
.639** .536** 1 .379** .685** -0.070 
Left Medial 
Frontal Gyrus 
Coefficients 
.521** .412** .379** 1 .429** 0.184 
Right 
Cerebellum 
Coefficients 
.649** .548** .685** .429** 1 -0.042 
CPT Average Hit 
Response Time  
0.100 0.109 -0.070 0.184 -0.042 1 
Notes. **. Correlation is significant at the 0.01 level (2-tailed).  *. Correlation is significant at the 0.05 level (2-tailed). 
 
Discussion 
 This study examined BOLD responses between cannabis users and controls during 
correct inhibitions of neutral NoGo stimuli. Further, we aimed to determine if gender moderates 
the impact of cannabis use on brain activation. The data showed that despite similar behavioral 
performance, adolescent and young adult cannabis users demonstrated increased and diffuse 
BOLD activation within regions associated with response inhibition even after three weeks of 
monitored abstinence. Gender did not moderate these effects. 
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 Our findings support previous work examining functional and behavioral differences in 
response inhibition between cannabis using adolescents and emerging adults and their non-using 
counterparts. Cannabis users showed increased BOLD responses within the left superior frontal 
gyrus and the left medial gyrus replicating previous findings (Gruber & Yurgelun-Todd, 2005; 
Tapert et al., 2007). Similar to past research, cannabis users also demonstrated greater BOLD 
activation during response inhibition in the left anterior cingulate cortex (Hester et al., 2009) and 
the thalamus (A. M. Smith et al., 2011). Further, as hypothesized, neighboring brain regions 
were incorporated showing increased BOLD responses with the significant cluster associated 
with the left cingulate cortex being particularly diffuse across the anterior cingulate cortex and 
pre-frontal regions of the brain. These findings add to the previous literature which have 
produced relatively consistent findings indicating increased BOLD responses in prefrontal 
(Behan et al., 2014; Hester et al., 2009; A. M. Smith et al., 2011; Tapert et al., 2007), ACC 
(Hester et al., 2009), and thalamus (A. M. Smith et al., 2011) regions. Gruber and colleagues 
(2005) did show mixed findings in the directionality of BOLD responses, which may be due to 
the use of differing task paradigms (i.e. Stroop versus Go-NoGo). Previous research suggests the 
use of the Stroop task may be measuring different mechanisms of inhibition, which differs from 
the more “pure” Go-NoGo inhibition task (Garavan et al., 2002; Nigg, 2000). Further, we 
previously reported, in an overlapping sample, that the cannabis users had impaired sustained 
attention on the CPT-3 task (Wallace et al., 2018) and this increased BOLD response was 
positively (although not significantly) correlated with poorer sustained attention. Taken together, 
this suggests that the increased BOLD response was not advantageous to the cannabis users.  
Other fMRI studies have also reported abnormalities in similar regions, including 
increased BOLD responses of the ACC during error monitoring (Hester et al., 2009) and visual 
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working memory (Kanayama, Rogowska, Pope, Gruber, & Yurgelun-Todd, 2004) tasks. Altered 
activation in prefrontal regions have also been observed during working memory (Alecia D 
Schweinsburg et al., 2005) and reward anticipation (Van Hell et al., 2010) tasks, although the 
directionality of the BOLD responses (increased vs decreased) remain mixed. Still, these results 
support the notion that chronic cannabis use affects brain regions dense in CB1 receptors such as 
the ACC (Herkenham et al., 1990). Animal models show that chronic cannabis use leads to a 
downregulation of CB1 receptors (González, Cebeira, & Fernández-Ruiz, 2005); therefore, 
impacting the natural functioning of the endogenous endocannabinoid system. With this 
downregulation in CB1 receptor functioning, differences in BOLD activation (as Tapert et al. 
(2007) suggests) may be compensatory in nature and indicating increased need for resources to 
perform similar inhibitory response as non-cannabis users in these CB1 rich brain regions. While 
these differences in brain functioning may not contribute to observable behavioral differences at 
this point of development, continued chronic use could produce downstream behavioral 
differences in later years as brain development becomes less plastic. Further exploration into 
CB1 receptor functioning and endocannabinoid signaling in the developing human brain may 
help elucidate the mechanistic link between chronic cannabis use and long-term neurocognitive 
deficits.  
This study examined inhibitory control within the context of an affective processing task. 
Therefore, in a follow-up analysis, we examined BOLD response to neutral NoGo stimuli during 
trials with happy Go stimuli and fearful Go stimuli. To examine the influence of this emotional 
environment, we compared BOLD responses during neutral NoGo inhibition within these two 
trials in cannabis users compared to controls. During the happy Go block, the areas of activation 
were similar to our main findings. However, there were no significant clusters that survived 
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corrections in the trials of the fearful Go stimuli. This suggests that the emotional environment 
did have an influence on the neuronal response to inhibition in the cannabis users compared to 
controls. However, the current power of this study does not support further investigation into the 
nature of these supplementary findings. Still, closer examination of how affective states 
influence brain responses during response inhibition must be conducted going forward to 
determine the true nature of this relationship.  
 Past findings have wisely pointed out that increased BOLD responses in cannabis users 
may be attributed to recent use, in part due to cardiovascular effects of acute cannabis use 
(Tapert et al., 2007). However, these increases in blood flow have been shown to vanish by 28 
days of last cannabis use (Sneider et al., 2008). Due to the requirement for cannabis users to 
remain abstinent for the 21 days leading up to MRI scan, participants last cannabis use on 
average occurred 31.08 days prior to scanning. This period of abstinence provides evidence that 
these changes in brain functioning are due to chronic cannabis use rather than acute effects. 
Indeed, this length of abstinence is linked with resolution of withdrawal symptoms and past work 
has shown recovery of cognitive deficits in cannabis users following sustained abstinence 
(Hanson et al., 2010; Medina et al., 2007; Schuster et al., 2018). Therefore, this sample of 
cannabis users may have demonstrated some recovery of function and findings may not 
generalize to more recent users. 
We did not find a significant interaction between cannabis use and gender on the effect of 
BOLD responses during correct inhibitory responses. It may be that cannabis use does not 
disproportionately affect brain functioning or performance between genders in these regions as 
previous animal models suggest (Burston et al., 2010; Paola Castelli et al., 2014). Investigations 
into gender effects for this cognitive domain remains relatively limited and findings are still 
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mixed. While functional studies have not examined gender differences in cannabis users, 
structural studies indicate that brain based differences do occur in frontolimbic areas in 
adolescent users (Battistella et al., 2014; Gilman et al., 2014; McQueeny et al., 2011; Schacht, 
Hutchison, & Filbey, 2012).  It is also possible that gender differences exist at earlier adolescent 
stages, but gender differences diminish by the early young adult years and the current sample 
average age was 20-21. Future studies are needed to examine how cannabis and gender interact 
to predict longitudinal neurodevelopment of neuronal areas underlying inhibitory control.   
It is also important to note that increased BOLD activity observed in cannabis users may 
be premorbid in nature; inherent brain differences in these regions may make individuals more 
susceptible to using cannabis in the adolescent and young adult years. Indeed, substance use has 
been heavily associated with impaired response inhibition (Ivanov et al., 2008) with substance 
users across varying forms of use having been consistently shown to have inhibitory deficits 
across a myriad of studies (J. L. Smith et al., 2014). With evidence pointing to deficits in 
response suppression in children with high family risk for alcohol use disorder (Nigg et al., 
2006), premorbid deficits of response inhibition may be a potential predictor of future substance 
use (Nigg et al., 2006; Squeglia, Jacobus, Nguyen-Louie, & Tapert, 2014). These findings are 
further replicated in fMRI studies. Most notably, longitudinal studies examining inhibitory 
control have shown that neural activity during inhibition response in adolescents can predict 
future substance use (Mahmood et al., 2013; Norman et al., 2011). Prospective, longitudinal 
studies are needed to determine whether these observed differences are predictors of cannabis 
use onset and increased use and/or direct effects of chronic exposure. 
Limitations should be noted. As noted above, the study’s cross-sectional nature prevents 
us from determining causality of these increased BOLD responses in cannabis users compared to 
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controls. Prospective, longitudinal studies, such as the Adolescent Brain Cognitive Development 
(ABCD) Study (Terry L Jernigan, Brown, & Dowling, 2018), will help determine timing and 
causality of these findings. Further, the study population was primarily Caucasian, relatively 
average to high average education levels, and did not have comorbid medical or physical 
disorders. This narrows the generalizability of the study, and more representative samples of the 
general population (i.e. the ABCD study) should be utilized to examine these effects in 
subgroups. 
 These findings lend support to the growing literature suggesting that adolescent and 
young adult cannabis users demonstrate increased BOLD responses during response inhibition. 
These findings suggest that regular cannabis during these neurodevelopmental years may impact 
neurodevelopment. Further prospective, longitudinal research is needed to determine causality 
and whether sustained abstinence greater than one month is associated with complete recovery 
from cannabis effects.   
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